Fluticason-Mepha 27.5 μg, Nasenspray, Suspension
7680693120013
CH-69312
Nasenspray
Associated product:
FLUTICASON Mepha spray nasal 27.5 mcg 120 dos
1 / 3
google
Article details
- Package size
- 120
- Selling units
- 120
- Measure
- Einzeldose(n)
- Galenic form
- Nasenspray
- Galenic group
- Nasenmittel
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
(N/A)
|
27.5 UG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
8.25 UG | Substance | Konservierungsstoff (Conservateur) |
|
(N/A)
|
- | Substance | HNIDK |
Reimbursement information
Public price
CHF 16.70
Specialties list
Yes
Generic
Yes
SL addition date:
01/01/2025
Authorization holder
Mepha Pharma AG
4051 Basel
Authorization information
- Swissmedic authorization number
- 69312
- Drug name
- Fluticason-Mepha, Nasenspray, Suspension
- Galenic form
- NASSS
- ATC Code
- R01AD12
- Authorization status
- Z
- Dispensing category
- B
- First authorization
- 18/07/2024
- Authorization expiration date
- 17/07/2029
- IT Number
- 12.02.3.
- Domain
- Human medicine
Package details
- Description (FR)
- FLUTICASON Mepha spray nasal 27.5 mcg 120 dos
- Description (DE)
- FLUTICASON Mepha Nasenspray 27.5 mcg 120 Dos
- Market launch
- 18/07/2024
- Narcotic (BTM)
- No
Original drug
Avamys, Nasenspray, Suspension
GTIN: 7680579680051
CHF 18.45